Mexico demands Boehringer Ingelheim/Sanofi animal health divestitures

European drugmakers Boehringer Ingelheim and Sanofi will have to sell five animal health vaccines to an approved third-party purchaser in Mexico to clear one of the few remaining antitrust hurdles facing the US$24.5 billion asset swap.


Get unlimited access to all Latin Lawyer content